Navigation Links
Chimerix and BARDA Reach Agreement Ending GAO Review of Smallpox Antiviral Contract
Date:6/27/2011

HALT Trial/CMX001-202); and an ongoing open-label study (CMX001-350) for the treatment of numerous dsDNA viral infections.  

CMX001 and Smallpox Antiviral Development

CMX001 is a leading antiviral candidate as a medical countermeasure against a smallpox release, including the potential to provide an important therapeutic option for the 80 million people in the U.S. currently estimated to be immunocompromised and thus not candidates to receive a smallpox vaccine.  Chimerix has received federal funding for the development of CMX001 as a medical countermeasure against smallpox from the National Institute of Allergy and Infectious Diseases under Grant No.UO1-AI057233 and from the Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response, Office of the Secretary, Department of Health and Human Services, under Contract No. HHSO100201100013C.

About Chimerix

Chimerix is developing novel antiviral therapeutics with the potential to transform patient care in multiple settings, including transplant, oncology, acute care and global health.

The company's lead candidate, CMX001, is being developed as a potential broad spectrum antiviral product for the treatment of life-threatening double-stranded DNA (dsDNA) viral diseases. To date, more than 500 patients have been dosed with CMX001 in placebo-controlled clinical trials and open-label treatment protocols, including over 250 individuals who have received CMX001 to help treat life-threatening dsDNA viral diseases for which there were no other therapeutic options.

Chimerix's second clinical-stage antiviral compound, CMX157, a potent nucleoside analogue with in vitro activity against HIV and hepatitis B, has the potential to directly address several limitations of current HIV therapies. Chimerix is developing CMX157 for the treatment of HIV and HBV infections, including those caused by multi-drug r
'/>"/>

SOURCE Chimerix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Chimerix to Present at Two Upcoming Investor Conferences
2. Chimerix Awarded BARDA Contract for Advanced Development of Broad Spectrum Antiviral CMX001 as Medical Countermeasure Against Smallpox
3. Chimerix Completes $45 Million Financing to Fund Further Development of Novel Antiviral Therapeutics CMX001 and CMX157
4. Chimerix Presents Update on CMX001 Development to the World Health Organization Advisory Committee on Variola Virus Research
5. Chimerixs PIM Conjugate Technology Reduces Risk of Nephrotoxicity for CMX001 and CMX157
6. Chimerix Appoints Two New Vice Presidents to Clinical Management Team
7. Chimerix to Present at Upcoming Investor Conferences
8. Chimerix Initiates Phase 1 Study of CMX157
9. Chimerix Names George Painter, Ph.D., Chairman of the Board and Chief Scientific Officer; Appoints Kenneth I. Moch President and Chief Executive Officer
10. Chimerix Names Wendy Painter, M.D., M.P.H., as Chief Medical Officer
11. Chimerix, Inc. Appoints Kenneth I. Moch Chief Operating Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... MORRIS PLAINS, New Jersey , 22. Juli ... Analysen für die Life-Sciences-Industrie, hat die Ernennung von ... bekanntgegeben. Herr Bergler hat die europäischen ... Strategische Lösungen unterstützt. Bevor er sich Qforma anschloss, ... Marketing bei Cegedim Customer Information, als Vertriebsteam-Leiter Deutschland ...
(Date:7/22/2014)... Dr. Williams says, “Bush has joined the constantly ... greatest health care system in the world is too ... trying to serve the public. Unfortunately, Bush has also ... enormous system that none of them can first describe ... of Open Letters ( http://is.gd/wdU2CM ) provides a critique ...
(Date:7/21/2014)... right amount of tension to a chain of carbon ... an insulator, according to Rice University scientists. , Stretching ... chain of carbon atoms -- by just 3 percent ... engineers might find useful for mechanically activated nanoscale electronics ... Boris Yakobson and his colleagues appears in the American ...
(Date:7/21/2014)... July 21, 2014  Mike Patterson, CEO of ... million in Series Seed B funding to finance ... for the life science, defense, intelligence, and environmental ... led the round and was joined by R2M ... Said Patterson , "This round of funding will ...
Breaking Biology Technology:Qforma gibt Schaffung des neuen Postens als General Manager in Europa bekannt 2Dr. Ira Williams Asks What’s Wrong With Jonathan Bush’s Book, Where Does It Hurt? 2Carbyne morphs when stretched 2Carbyne morphs when stretched 3Global Graphene Manufacturing Leader, Graphene Frontiers, Receives Series Seed B Funding To Assure Production Of The Next Generation Of Biological And Chemical Sensor Technology 2
... president and CEO Michael J. Collins delivered the commencement address ... Department, which was held on May 18, 2012. Collins received ... been a member of the Advisory Board for the Chemistry ... (Logo: http://photos.prnewswire.com/prnh/20090622/CL35336LOGO-b ) "I am ...
... one in four adults suffering from a diagnosable ... high case loads, the value of independent living ... effective mental health services. ILCs are generally thought ... physical disabilities, but across the country, directors and ...
... 24, 2012  Novocure™, a commercial stage private oncology company, ... of excellence will join the seven existing clinical centers ... patients with recurrent GBM. These fifteen clinical centers are ... GBM is both the deadliest and most ...
Cached Biology Technology:CEM President and CEO Delivers Commencement Address at the 2012 University of Texas at Austin Chemistry and Biochemistry Department Graduation 2Peers Underscored As An Effective Counseling Tool 2Novocure™ Certifies Eight Additional Clinical Centers of Excellence to Treat Most Common Brain Tumor with Tumor Treating Fields (TTFields) Therapy 2Novocure™ Certifies Eight Additional Clinical Centers of Excellence to Treat Most Common Brain Tumor with Tumor Treating Fields (TTFields) Therapy 3Novocure™ Certifies Eight Additional Clinical Centers of Excellence to Treat Most Common Brain Tumor with Tumor Treating Fields (TTFields) Therapy 4
(Date:7/21/2014)... in dopamine signaling profoundly changes the activity level ... cortex and may be an underlying cause of ... to UC Irvine scientists. , This epigenetic alteration ... this neurotransmitter showed for the first time that ... and physiological functions regulated in the prefrontal cortex. ...
(Date:7/21/2014)... antibiotic resistance, and cheating in science are among ... virology, and mycology experts in Montreal at the ... from July 27 to August 1, 2014. Some ... expected at the 14th International Congress of Bacteriology ... Mycology and Eukaryotic Microbiology, and the 16th International ...
(Date:7/21/2014)... INRS nergie Matriaux Tlcommunications Research Centre successfully imaged ... resolution greatly exceeding that obtained to date using ... to shoot a molecular movie of how an ... the advancement was recently published in the scientific ... approach we developed combines multiphoton ionization and Coulomb ...
Breaking Biology News(10 mins):UCI researchers find epigenetic tie to neuropsychiatric disorders 2Montreal hosts International Union of Microbiology Societies congresses 2
... 4-28-09. InDevR, a small biotech company in Boulder, CO, ... the University of Colorado. The FluChip was invented by ... and the Centers for Disease Control and Prevention in an ... Rowlen, now the CEO of InDevR, said that InDevR ...
... research grants totaling $24 million in U.S. dollars ... and hospitals to fund studies related to asthma ... and cancer. The extramural grants were awarded ... (Agency for Science, Technology and Research), the government ...
... The Entomological Society of America (ESA) will feature ... Meeting in Indianapolis, December 13-16, 2009. Integrative ... Cold Case Files: Integrative Perspectives on Physiological ... Evolutionary Arms Race of Resistance in Herbivores ...
Cached Biology News:FluChip technology licensed to combat deadly flu virus 2Alzheimer's, asthma, cancer, malaria and TB focus of new Singapore grants 2Alzheimer's, asthma, cancer, malaria and TB focus of new Singapore grants 3Alzheimer's, asthma, cancer, malaria and TB focus of new Singapore grants 4Symposia selected for Entomological Society of America meeting 2Symposia selected for Entomological Society of America meeting 3Symposia selected for Entomological Society of America meeting 4
Rat neural stem cell kits are intended for the in vitro growth and commitment to neuronal and glial lineage differentiation, of cultured fetal rat neural stem and progenitor cells expanded using FGF-...
MOUSE ANTI POLY (ADP-RIBOSE) Immunogen: Purified poly (ADP-ribose) polymer, 10-50 unit chain length...
Edited by D. Patel (1994) Comprehensive data on gel electrophoresis of proteins, nucleic acids, nucleoproteins and carbohydrates....
... Walker (1996) • This book offers ... studying proteins and peptides. Each tried ... instruction, timesaving troubleshooting tips, alternative procedures, ... reagents and suppliers. Topics covered range ...
Biology Products: